NDC product
Quetiapine Fumarate Extended Release
NDC 0310-8284 · AstraZeneca Pharmaceuticals LP
Key facts
| Product NDC | 0310-8284 |
|---|---|
| Proprietary name | Quetiapine Fumarate |
| Labeler | AstraZeneca Pharmaceuticals LP |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA022047 |
| Marketing start | May 1, 2017 |
| Marketing end | Feb 28, 2021 |
| Listing certified through | Feb 28, 2021 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: